Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Recent progress and structural analyses of domain‐selective BET inhibitors
Anand Divakaran, Daniel A. Harki, William C. K. Pomerantz
Medicinal Research Reviews (2023) Vol. 43, Iss. 4, pp. 972-1018
Open Access | Times Cited: 18

Showing 18 citing articles:

Pore structure characteristics, modulation and its effect on concrete properties: A review
Jianzhuang Xiao, Zhenyuan Lv, Zhenhua Duan, et al.
Construction and Building Materials (2023) Vol. 397, pp. 132430-132430
Closed Access | Times Cited: 81
Discovery of a Bromodomain and Extra Terminal Domain (BET) Inhibitor with the Selectivity for the Second Bromodomain (BD2) and the Capacity for the Treatment of Inflammatory Diseases
Zhijie Wang, Li Yin, Zhenghan Xiong, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 15, pp. 10824-10848
Closed Access | Times Cited: 13
Structure-Guided Design and Synthesis of Pyridinone-Based Selective Bromodomain and Extra-Terminal Domain (BET)-First Bromodomain (BD1) Inhibitors
Yangfeng Li, Zhengnan Shen, Kiira Ratia, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 4, pp. 2712-2731
Closed Access | Times Cited: 5
Humanized Candida and NanoBiT Assays Expedite Discovery of Bdf1 Bromodomain Inhibitors With Antifungal Potential
Kaiyao Wei, Marie Arlotto, Justin M. Overhulse, et al.
Advanced Science (2025)
Open Access
Binding Selectivity of Inhibitors to BRD2 Uncovered by Molecular Docking and Molecular Dynamics Simulations
Qian Bai, Ruige Wang, Shili Qin, et al.
Advanced Theory and Simulations (2025)
Closed Access
Multi-Water Bridges Enable Design of BET BD1-Selective Inhibitors for Pancreatic Cancer Therapy
Xuetao Chen, Wenjing Kang, Tingting Wu, et al.
Journal of Medicinal Chemistry (2025)
Closed Access
A Minireview on BET Inhibitors: Beyond Bromodomain Targeting
Mikhail Iudin, Yu. M. Khodarovich, Anna M. Varizhuk, et al.
Biomedicines (2025) Vol. 13, Iss. 3, pp. 594-594
Open Access
Discovery of the First BRD4 Second Bromodomain (BD2)-Selective Inhibitors
Junhua Li, Qingqing Hu, Run Zhu, et al.
Journal of Medicinal Chemistry (2024)
Closed Access | Times Cited: 3
Targeting the epigenetic reader “BET” as a therapeutic strategy for cancer
Abhishek Wahi, Namish Manchanda, Priti Jain, et al.
Bioorganic Chemistry (2023) Vol. 140, pp. 106833-106833
Closed Access | Times Cited: 7
Discovery of a brain-permeable bromodomain and extra terminal domain (BET) inhibitor with selectivity for BD1 for the treatment of multiple sclerosis
Xuetao Chen, Tingting Wu, Zhiyan Du, et al.
European Journal of Medicinal Chemistry (2023) Vol. 265, pp. 116080-116080
Closed Access | Times Cited: 7
Targeting bromodomian-containing protein 8 (BRD8): An advanced tool to interrogate BRD8
Tingting Wu, Yali Chen, Qidong You, et al.
European Journal of Medicinal Chemistry (2024) Vol. 268, pp. 116271-116271
Closed Access | Times Cited: 1
Zinc-chelating BET bromodomain inhibitors equally target islet endocrine cell types
Rachel A. Jones, Jennifer S. Stancill, Raymundo Nuñez, et al.
AJP Regulatory Integrative and Comparative Physiology (2024) Vol. 326, Iss. 6, pp. R515-R527
Closed Access | Times Cited: 1
Development and Evaluation of [11C]I-58: A Novel PET Radiotracer Targeting BRD4 BD2 for Advanced Epigenetic Imaging
Yanli Wang, Yongle Wang, Yulong Xu, et al.
ACS Omega (2024)
Open Access | Times Cited: 1
BRD4 promotes immune escape of glioma cells by upregulating PD-L1 expression
Yongsheng Liu, Lize Cai, Hao Wang, et al.
Journal of Neuro-Oncology (2024) Vol. 171, Iss. 3, pp. 669-679
Closed Access | Times Cited: 1
Targeting Epigenetic Regulators with HDAC and BET Inhibitors to Modulate Muscle Wasting
L. Nevi, Noora Pöllänen, Fabio Penna, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 22, pp. 16404-16404
Open Access | Times Cited: 3
Discovery of novel bromodomain-containing protein 4 (BRD4-BD1) inhibitors combined with 3d-QSAR, molecular docking and molecular dynamics in silico
Rong Liu, XiaoDie Chen, Jiali Li, et al.
Journal of Biomolecular Structure and Dynamics (2024), pp. 1-18
Closed Access
Marine natural product-inspired discovery of novel BRD4 inhibitors with anti-inflammatory activity
Shuxia Chen, Jichen Yang, Xiangyu Wang, et al.
European Journal of Medicinal Chemistry (2024) Vol. 284, pp. 117193-117193
Closed Access
Selectivity Mechanism of Pyrrolopyridone Analogues Targeting Bromodomain 2 of Bromodomain-Containing Protein 4 from Molecular Dynamics Simulations
Mingsong Shi, Xueting Zheng, Yan Zhou, et al.
ACS Omega (2023) Vol. 8, Iss. 37, pp. 33658-33674
Open Access
Page 1

Scroll to top